Literature DB >> 10209010

Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient.

A Deussen1, M Stappert, S Schäfer, M Kelm.   

Abstract

BACKGROUND: Inhibitors of adenosine membrane transport cause vasodilation and enhance the plasma adenosine concentration. However, it is unclear why the plasma adenosine concentration rises rather than falls when membrane transport is inhibited. We tested the hypothesis that the cytosolic adenosine concentration exceeds the interstitial concentration under well-oxygenated conditions. METHODS AND
RESULTS: In isolated, isovolumically working guinea pig hearts (n=50), the release rate of adenosine and accumulation of S-adenosylhomocysteine (after 20 minutes of 200 micromol/L homocysteine), a measure of the free cytosolic adenosine concentration, were determined in the absence and presence of specific and powerful blockers of adenosine membrane transport (nitrobenzylthioinosine 1 micromol/L), adenosine deaminase (erythro-9-hydroxy-nonyl-adenine 5 micromol/L), and adenosine kinase (iodotubericidine 10 micromol/L). Data analysis with a distributed multicompartment model revealed a total cardiac adenosine production rate of 2294 pmol. min-1. g-1, of which 8% was produced in the extracellular region. Because of a high rate of intracellular metabolism, however, 70.3% of extracellularly produced adenosine was taken up into cellular regions, an effect that was effectively eliminated by membrane transport block. The resulting approximately 2.8-fold increase of the interstitial adenosine concentration evoked near-maximal coronary dilation.
CONCLUSIONS: We rejected the hypothesis that the cytosolic adenosine concentration exceeds the interstitial. Rather, there is significant extracellular production, and the parenchymal cell represents a sink, not a source, for adenosine under well-oxygenated conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209010     DOI: 10.1161/01.cir.99.15.2041

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters.

Authors:  Marzena Podgorska; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

2.  Methotrexate modulates the kinetics of adenosine in humans in vivo.

Authors:  N P Riksen; P Barrera; P H H van den Broek; P L C M van Riel; P Smits; G A Rongen
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

3.  A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.

Authors:  Bernard J C Macatangay; Edwin K Jackson; Kaleab Z Abebe; Diane Comer; Joshua Cyktor; Cynthia Klamar-Blain; Luann Borowski; Delbert G Gillespie; John W Mellors; Charles R Rinaldo; Sharon A Riddler
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

4.  Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: role of adenosine transporters.

Authors:  J Lynge; C Juel; Y Hellsten
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

5.  Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation.

Authors:  Ole Frøbert; Gesine Haink; Ulf Simonsen; Claus H Gravholt; Max Levin; Andreas Deussen
Journal:  J Physiol       Date:  2005-11-10       Impact factor: 5.182

6.  Adenosine kinase regulation of cardiomyocyte hypertrophy.

Authors:  John T Fassett; Xinli Hu; Xin Xu; Zhongbing Lu; Ping Zhang; Yingjie Chen; Robert J Bache
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

7.  Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.

Authors:  Richard G E Archer; Václav Pitelka; James R Hammond
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

8.  CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system.

Authors:  Deeqa A Mahamed; Jeffrey H Mills; Charlotte E Egan; Eric Y Denkers; Margaret S Bynoe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

Review 9.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

Review 10.  Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.

Authors:  Gabriel S Chiu; Gregory G Freund
Journal:  Metabolism       Date:  2014-09-26       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.